Psychedelics Market Update: H1 2025 in Review
Jul 30, 2025 01:15PM PST
Discover what's been driving growth in the psychedelics market, and what may be next for this emerging healthcare sector.
Life Science Investing
Latest Articles
Biotech and Pharma Market Update: Q2 2025 in Review
Jul 24, 2025 01:15PM PST
Life Science Investing NewsMore Articles
Company Profiles
CDX:AU
Cardiex Limited
Biomarker technologies and digital solutions to address the world’s largest health disorders.
RAD:AU
Radiopharm Theranostics
Developing innovative radiopharmaceuticals for a highly underserved oncology sector
CEO Interviews
More CEO Interviews
life science News
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders
GeographyMay 29, 2025 02:27AM PST
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT
GeographyMay 27, 2025 02:27AM PST
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors
GeographyApr 29, 2025 02:27AM PST
Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
GeographyApr 16, 2025 02:27AM PST
Cizzle Brands' CWENCH Hydration Becomes USA Hockey's Official Hydration Partner
Company NewsApr 3, 2025 02:55AM PST
International
Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update
GeographyJul 29, 2025 02:30AM PST
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
GeographyJul 28, 2025 03:00AM PST
Editors' Picks
More Editors' Picks
